Probiotics Dietary Supplement Market - Forecasts from 2017 to 2022

October 2017 | 108 pages | ID: P32EB9AC816EN
Knowledge Sourcing Intelligence LLP

Abstracts

Probiotics dietary supplement market is projected to witness a CAGR of 8.09% during the forecast period to reach a total market size of US$10.225 billion by 2022, increasing from US$6.928 billion in 2017. Shifting people focus towards health and fitness is augmenting the need for nutritional diet while propelling demand for probiotics dietary supplements. In addition, growing number of digestive ailments among different age groups coupled with growing prevalence of chronic diseases is further contributing to the market growth. Other drivers include expanding urbanization, increasing disposable income along with changing lifestyle in developing countries. By application, the nutritional supplement is expected to grow at the high CAGR over the projected period. Growing demand for nutritional diet owing to mounting concern over health and fitness propel the segment growth.

Asia Pacific is expected to grow at the highest rate over the projected period. Large customer base coupled with rapidly urbanizing society drive the regional growth. The growing disposable income as well as increasing disease prevalence further contributes to the APAC market growth. Other drivers include growing demand for infant formula owing to rising awareness among parents about its benefits and increasing local players.

The Probiotics Dietary Supplement market is highly competition owing to the presence of numerous small and large vendors. Some of the key players discussed in the report include DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and Kibow Biotech among others. New product launch owing to continuous R&D and industry integrations are the major strategies being adopted by players to differentiate themselves from the competition.

Segmentation

Probiotics Dietary Supplement market has been segmented by strain type, sales channel, application, and geography.

By Strain Type

Lactobacillus
Bifidobacterium
Others
By Sale Channel

Hypermarket
Specialty store
Pharmacies
Independent Retailers
Direct Sellers
Online
By Application

Food Supplements
Speciality Nutrients
Infant Formula
Nutritional Supplements
By Geography

North America
United States
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East and Africa
UAE
Saudi Arabia
Others
Asia Pacific
Japan
China
India
South Korea
Australia
Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis

5. GLOBAL PROBIOTICS DIETARY SUPPLEMENT MARKET FORECAST BY STRAIN TYPE (US$ BILLION)

5.1. Introduction
5.2. Lactobacillus
5.3. Bifidobacterium
5.4. Others

6. GLOBAL PROBIOTICS DIETARY SUPPLEMENT MARKET FORECAST BY SALES CHANNEL (US$ BILLION)

6.1. Introduction
6.2. Hypermarket
6.3. Specialty store
6.4. Pharmacies
6.5. Independent Retailers
6.6. Direct Sellers
6.7. Online

7. GLOBAL PROBIOTICS DIETARY SUPPLEMENT MARKET FORECAST BY APPLICATION (US$ BILLION)

7.1. Introduction
7.2. Food Supplements
7.3. Speciality Nutrients
7.4. Infant Formula
7.5. Nutritional Supplements

8. GLOBAL PROBIOTICS DIETARY SUPPLEMENT MARKET FORECAST BY GEOGRAPHY (US$ BILLION)

8.1. North America
  8.1.1. United States
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. United Kingdom
  8.3.2. Germany
  8.3.3. France
  8.3.4. Italy
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. UAE
  8.4.2. Saudi Arabia
  8.4.3. Others
8.5. Asia Pacific
  8.5.1. Japan
  8.5.2. China
  8.5.3. India
  8.5.4. South Korea
  8.5.5. Australia
  8.5.6. Others

9. COMPETITIVE INTELLIGENCE

9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. COMPANY PROFILES

10.1. DowDuPont Inc.
  10.1.1. Overview
  10.1.2. Financials
  10.1.3. Products and Services
  10.1.4. Key Developments
10.2. Chr. Hansen Holding A/S
  10.2.1. Overview
  10.2.2. Financials
  10.2.3. Products and Services
  10.2.4. Key Developments
10.3. Cargill
  10.3.1. Overview
  10.3.2. Financials
  10.3.3. Products and Services
  10.3.4. Key Developments
10.4. Lifeway Foods, Inc.
  10.4.1. Overview
  10.4.2. Financials
  10.4.3. Products and Services
  10.4.4. Key Developments
10.5. Kibow Biotech
  10.5.1. Overview
  10.5.2. Financials
  10.5.3. Products and Services
  10.5.4. Key Developments
10.6. Pharmavite LLC
  10.6.1. Overview
  10.6.2. Financials
  10.6.3. Products and Services
  10.6.4. Key Developments
10.7. Osmotica Pharmaceuticals Corp
  10.7.1. Overview
  10.7.2. Financials
  10.7.3. Products and Services
  10.7.4. Key Developments
10.8. Dietary Pros, Inc.
  10.8.1. Overview
  10.8.2. Financials
  10.8.3. Products and Services
  10.8.4. Key Developments
10.9. Royal DSM
  10.9.1. Overview
  10.9.2. Financials
  10.9.3. Products and Services
  10.9.4. Key Developments
10.10. Yakult
  10.10.1. Overview
  10.10.2. Financials
  10.10.3. Products and Services
  10.10.4. Key Developments